The learned intermediary doctrine after FDA’s drug watch and PhRMA’s clinical study results database: shifting the focus of failure-to-warn claims.(Pharmaceutical … An article from: Defense Counsel Journal
By
Product Description
This digital document is an article from Defense Counsel Journal, published by Thomson Gale on January 1, 2006. The length of the article is 6591 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: The learned intermediary doctrine after FDA’s drug watch and PhRMA’s clinical study results database: shifting the focus of failure-to-warn claims.(Pharmaceutical Researchers and Manufacturers Association)
Author: Stephen E. Scheve
Publication: Defense Counsel Journal (Magazine/Journal)
Date: January 1, 2006
Publisher: Thomson Gale
Volume: 73 Issue: 1 Page: 12(10)
Distributed by Thomson Gale
The learned intermediary doctrine after FDA’s drug watch and PhRMA’s clinical study results database: shifting the focus of failure-to-warn claims.(Pharmaceutical … An article from: Defense Counsel Journal
